The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Gastroenterology · 2012 · 1.8K citations · Full text

Medicine, Internal Medicine, Gastroenterology +15

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

Lidia S. Szczepaniak, Pamela Nurenberg, David Léonard et al. · American Journal of Physiology-Endocrinology and Metabolism · 2004 · 1.6K citations

Medicine, Nutrition, Clinical Nutrition +16

A position statement on NAFLD/NASH based on the EASL 2009 special conference

Vlad Ratziu, Stefano Bellentani, Helena Cortez‐Pinto et al. · Journal of Hepatology · 2010 · 1.1K citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +14

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

John B. Dixon, Prithi S. Bhathal, Norman R. Hughes et al. · Hepatology · 2004 · 727 citations · Full text

Medicine, Internal Medicine, Pathology +17